These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18647967)

  • 1. A clinicopathological study of nm23-H1 expression in classical Hodgkin's lymphoma.
    Niitsu N; Nakamine H; Okamoto M; Tamaru JI; Hirano M
    Ann Oncol; 2008 Nov; 19(11):1941-6. PubMed ID: 18647967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of intracytoplasmic nm23-H1 expression in diffuse large B-cell lymphoma.
    Niitsu N; Nakamine H; Okamoto M; Akamatsu H; Higashihara M; Honma Y; Okabe-Kado J; Hirano M
    Clin Cancer Res; 2004 Apr; 10(7):2482-90. PubMed ID: 15073128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma.
    Niitsu N; Nakamine H; Okamoto M; Akamatsu H; Honma Y; Higashihara M; Okabe-Kado J; Hirano M;
    Br J Haematol; 2003 Nov; 123(4):621-30. PubMed ID: 14616965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of the differentiation inhibitory factor nm23-H1 protein in the plasma of aggressive non-Hodgkin's lymphoma.
    Niitsu N; Okabe-Kado J; Kasukabe T; Yamamoto-Yamaguchi Y; Umeda M; Honma Y
    Blood; 1999 Nov; 94(10):3541-50. PubMed ID: 10552965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic significance of CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's Lymphoma].
    Fu XH; Wang SS; Huang Y; Xiao J; Zhai LZ; Xia ZJ; Huang HQ; Sun XF; Lin TY
    Ai Zheng; 2008 Nov; 27(11):1197-203. PubMed ID: 19000453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. nm23-H1 expression in non-Hodgkin and Hodgkin lymphomas.
    Bircan S; Inamdar KV; Rassidakis GZ; Medeiros LJ
    Appl Immunohistochem Mol Morphol; 2008 May; 16(3):207-14. PubMed ID: 18301251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma.
    Niitsu N; Honma Y; Iijima K; Takagi T; Higashihara M; Sawada U; Okabe-Kado J
    Leukemia; 2003 Jan; 17(1):196-202. PubMed ID: 12529678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness.
    Aryee DN; Simonitsch I; Mosberger I; Kos K; Mann G; Schlögl E; Pötschger U; Gadner H; Radaszkiewicz T; Kovar H
    Br J Cancer; 1996 Dec; 74(11):1693-8. PubMed ID: 8956779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression and clinical significance of nm23-H1 and MUC-1 in peripheral T-cell lymphoma].
    Huang HQ; Pan ZH; Lin XB; Wang BF; Hou JH; Zhang Y; Wu QL
    Ai Zheng; 2006 Dec; 25(12):1517-23. PubMed ID: 17166378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of nm23-H1 expression with a poor prognosis in patients with peripheral T-cell lymphoma, not otherwise specified.
    Niitsu N
    J Clin Exp Hematop; 2014; 54(3):171-7. PubMed ID: 25501107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum nm23-H1 protein as a prognostic factor in hematological malignancies.
    Okabe-Kado J
    Leuk Lymphoma; 2002 Apr; 43(4):859-67. PubMed ID: 12153176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma.
    Niitsu N; Okabe-Kado J; Okamoto M; Takagi T; Yoshida T; Aoki S; Hirano M; Honma Y
    Blood; 2001 Mar; 97(5):1202-10. PubMed ID: 11222361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum nm23-H1 protein as a prognostic factor for indolent non-Hodgkin's lymphoma.
    Niitsu N; Okamoto M; Okabe-Kado J; Takagi T; Yoshida T; Aoki S; Honma Y; Hirano M
    Leukemia; 2001 May; 15(5):832-9. PubMed ID: 11368446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. nm23-H1 protein expression and gene mutation in 150 patients with non-Hodgkin's lymphomas.
    Lee JH; Cho SJ; Zhang X; Zheng Z; Lee ES; Kim A; Kim YS; Chae YS; Kim I
    J Korean Med Sci; 2006 Aug; 21(4):645-51. PubMed ID: 16891807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.
    Karube K; Niino D; Kimura Y; Ohshima K
    Pathol Res Pract; 2013 Apr; 209(4):201-7. PubMed ID: 23478005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcome.
    Andersen MD; Kamper P; Nielsen PS; Bendix K; Riber-Hansen R; Steiniche T; Hamilton-Dutoit S; Clausen M; d'Amore F
    Eur J Haematol; 2016 Mar; 96(3):252-9. PubMed ID: 25963595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancer.
    Khaled HM; Bahnassy AA; Raafat AA; Zekri AR; Madboul MS; Mokhtar NM
    BMC Cancer; 2009 Jan; 9():32. PubMed ID: 19171060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
    Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
    Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LGALS3 as a prognostic factor for classical Hodgkin's lymphoma.
    Koh YW; Jung SJ; Park CS; Yoon DH; Suh C; Huh J
    Mod Pathol; 2014 Oct; 27(10):1338-44. PubMed ID: 24603587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study.
    Asano N; Oshiro A; Matsuo K; Kagami Y; Ishida F; Suzuki R; Kinoshita T; Shimoyama Y; Tamaru J; Yoshino T; Kitamura K; Fukutani H; Morishima Y; Nakamura S
    J Clin Oncol; 2006 Oct; 24(28):4626-33. PubMed ID: 16954517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.